These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20002508)

  • 1. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.
    Straczek C; Ducimetiere P; Barberger-Gateau P; Helmer C; Ritchie K; Jouven X; Carcaillon L; Amouyel P; Tzourio C; Empana JP
    J Am Geriatr Soc; 2010 Jan; 58(1):129-35. PubMed ID: 20002508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
    Miller M; Zhan M; Havas S
    Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J;
    Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A; Can G; Hergenç G
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
    van der Meer IM; de Maat MP; Kiliaan AJ; van der Kuip DA; Hofman A; Witteman JC
    Arch Intern Med; 2003 Jun; 163(11):1323-8. PubMed ID: 12796068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
    Koenig W; Löwel H; Baumert J; Meisinger C
    Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and interleukin-18 levels in relation to coronary heart disease: prospective cohort study from Busselton Western Australia.
    Hung J; Knuiman MW; Divitini ML; Langton PE; Chapman CL; Beilby JP
    Heart Lung Circ; 2008 Apr; 17(2):90-5. PubMed ID: 17851127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on C-reactive protein and the risk factors of traditional coronary heart disease].
    Guo ZR; Hu XS; Chen FM; Wu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1064-8. PubMed ID: 18396656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
    Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
    Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Koenig W; Khuseyinova N; Baumert J; Thorand B; Loewel H; Chambless L; Meisinger C; Schneider A; Martin S; Kolb H; Herder C
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2745-51. PubMed ID: 17008587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
    Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
    Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
    Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
    Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
    Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
    Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
    Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
    Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
    Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.